| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 3-(1，3-dioxolan-2-yl)phenol |
克立硼羅雜質(zhì)71 |
7070-85-1 |
詳細
|
| 1，3-Dichloro-2-Methylpropane |
1,3-DICHLORO-2-METHYLPROPANE |
616-19-3 |
詳細
|
| 1-Phenylpropane-1，2-Diol |
PHENYLPROPANEDIOL |
1855-09-0 |
詳細
|
| Sulfamic Acid Methyl Ester |
氨基磺酸甲酯 |
55665-95-7 |
詳細
|
| 1，2-bis(4，5-dihydrothiazol-2-yl)disulfane |
2,2'-二硫基雙-2-噻唑啉 |
2801-13-0 |
詳細
|
| 3-hydroxypiperidine-2-carboxylic acid |
|
56879-47-1 |
詳細
|
| TD-106（3-(5-amino-4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)piperidine-2,6-dione） |
TD-106 |
2250288-69-6 |
詳細
|
| Thalidomide-NH-CH2-COO(t-Bu) |
沙利度胺-NH-C2-NH-COO(T-BU) |
2093386-23-1 |
詳細
|
| Thalidomide-NH-(CH2)2-NH-Boc |
沙利度胺-NH-C2-NH-Boc |
1957235-57-2 |
詳細
|
| Thalidomide-NH-(CH2)2-NH2 TFA |
沙利度胺-NH-C2-NH2三氟醋酸鹽 |
1957235-67-4 |
詳細
|
| Thalidomide-NH-(CH2)3-NH-Boc |
沙利度胺-NH-C3-NH-BOC |
2093386-36-6 |
詳細
|
| Thalidomide-5-NH-CH2-COO(t-Bu) |
THALIDOMIDE-5-NH-CH2-COO(T-BU) |
2412056-28-9 |
詳細
|
| Thalidomide-5-O-CH2-COO(t-Bu) |
ACETIC ACID, 2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-5-YL]OXY]-, 1,1-DIME |
2682112-10-1 |
詳細
|
| Thalidomide-5-O-CH2-COOH |
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚-5-基)氧基)乙酸 |
2467425-53-0 |
詳細
|
| Thalidomide-4-propargyl |
2-(2,6-dioxopiperidin-3-yl)-4-(prop-2-yn-1-yloxy)isoindoline-1,3-dione |
2098487-39-7 |
詳細
|
| Thalidomide-4-NH-PEG1-NH-Boc |
沙利度胺-NH-PEG1-NH-BOC |
2154342-17-1 |
詳細
|
| Thalidomide-4-NH-PEG1-COO(t-Bu) |
PROPANOIC ACID, 3-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]ETHO |
2140807-19-6 |
詳細
|
| Thalidomide-4-NH-PEG2-COO(t-Bu) |
PROPANOIC ACID, 3-[2-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]E |
2140807-16-3 |
詳細
|
| VH032-NH-CO-CH2-Br |
|
2379404-33-6 |
詳細
|
| VH032-NH-CO-CH2-NHBoc |
VH032-BOC-氨基 |
2010986-19-1 |
詳細
|
| VH032-NH-CO-CH2-NH2 |
(2S,4R)-1-((S)-2-(2-氨基乙酰胺基)-3,3-二甲基丁酰基)-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2010986-20-4 |
詳細
|
| INDEX NAME NOT YET ASSIGNED |
標準品RN1331 |
2111829-84-4 |
詳細
|
| L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- |
標準品RN1332 |
1448189-66-9 |
詳細
|
| L-Prolinamide, N-[4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxobutyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- |
標準品RN1333 |
2361119-87-9 |
詳細
|
| L-Prolinamide, N-[6-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxohexyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- |
標準品RN1334 |
2412055-00-4 |
詳細
|
| L-Prolinamide, N-[8-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxooctyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- |
標準品RN1335 |
2306389-02-4 |
詳細
|
| L-Prolinamide, N-[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- |
標準品RN1336 |
2409007-41-4 |
詳細
|
| L-Prolinamide, N-(12,12-dimethyl-1,10-dioxo-3,6,11-trioxa-9-azatridec-1-yl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- |
標準品RN1337 |
2162120-75-2 |
詳細
|
| INDEX NAME NOT YET ASSIGNED |
標準品RN1338 |
2827750-24-1 |
詳細
|
| INDEX NAME NOT YET ASSIGNED |
標準品RN1339 |
2827750-25-2 |
詳細
|
| (Z)-Methyl 3-Aminobut-2-Enoate |
Β-氨基巴豆酸甲酯 |
21731-17-9 |
詳細
|
| Ethyl (Z)-3-Aminobut-2-Enoate |
3-氨基巴豆酸乙酯 |
626-34-6 |
詳細
|
| Ethyl (E)-3-Ethoxybut-2-Enoate |
3-乙氧基-2-丁烯酸乙酯 |
57592-45-7 |
詳細
|
| 1-(pyridin-4-yl)urea |
(吡啶-4-基)脲 |
13262-38-9 |
詳細
|
| 1,3-di(pyridin-4-yl)urea |
N,N'-DI-4-PYRIDINYLUREA |
39642-87-0 |
詳細
|
| picolinoyl chloride |
2-吡啶甲酰氯 |
29745-44-6 |
詳細
|
| 3-oxobutanal |
乙酰乙醛 |
625-34-3 |
詳細
|
| Cholesta-3,5-dien-7-one |
cholesta-3,5-dien-7-one |
567-72-6 |
詳細
|
| Aprepitant Impurity 2 |
阿瑞匹坦中間體 |
171482-05-6 |
詳細
|
| Betahistine Impurity 4 |
2-(羥甲基)-2-(吡啶-2-基)丙烷-1,3-二醇 |
37445-98-0 |
詳細
|
| Cefditoren sodium |
頭孢妥侖鈉 |
104146-53-4 |
詳細
|
| Chlorphenamine EP Impurity C |
N-desmethylchlorpheniramine |
20619-12-9 |
詳細
|
| Dexrazoxane impurity 7 |
右雷佐生雜質(zhì)5 |
2084092-82-8 |
詳細
|
| Dexrazoxane impurity 8 |
右雷佐生雜質(zhì)5 |
2084092-84-0 |
詳細
|
| Dexrazoxane impurity 12 |
右丙亞胺雜質(zhì)3 |
120418-76-0 |
詳細
|
| Edoxaban impurity 13 |
依度沙班雜質(zhì)C(鹽酸鹽) |
1243308-37-3 |
詳細
|
| Fosaprepitant impurity 3 |
阿瑞吡坦磷的二卞酯 |
265121-01-5 |
詳細
|
| Fosaprepitant impurity 4 |
福沙匹坦-SSR對映異構(gòu)體 |
1523569-86-9 |
詳細
|
| Fosaprepitant impurity 5 |
Fosaprepitant diMegluMine Impurity 2 |
1185503-00-7 |
詳細
|
| Fosaprepitant impurity 6 |
|
2514928-37-9 |
詳細
|
| Fosaprepitant impurity 7 |
Fosaprepitant Impurity 1 |
172822-01-4 |
詳細
|
| Fosaprepitant impurity 8 |
Fosaprepitant diMegluMine Impurity 4 |
1523569-89-2 |
詳細
|
| Fusidic Acid EP Impurity J（ Sodium Fusidate EP Impurity J） |
夫西地酸(褐霉酸)雜質(zhì)J(EP) |
13011-12-6 |
詳細
|
| Fusidic Acid EP Impurity O（ Sodium Fusidate EP Impurity O） |
夫西地酸雜質(zhì)O |
13090-91-0 |
詳細
|
| Formoterol Impurity 1 |
(R)-1-(4-芐氧基-3-硝基苯基)-2-溴乙醇 |
188690-82-6 |
詳細
|
| Gadobutrol Impurity 7 |
釓布醇雜質(zhì)72 |
54364-78-2 |
詳細
|
| Gemcitabine EP Impurity B |
吉西他濱雜質(zhì)B |
95058-85-8 |
詳細
|
| Gemcitabine EP Impurity B HCl |
1'-吉西他濱異構(gòu)體鹽酸鹽 |
122111-05-1 |
詳細
|
| Gemcitabine impurity 4 |
吉西他濱雜質(zhì)31 |
866473-31-6 |
詳細
|
| Gemcitabine impurity 5 |
吉西他濱雜質(zhì)32 |
1258595-49-1 |
詳細
|
| Gemcitabine impurity 6 |
2,2-二氟-1-甲磺酰氧基-2-脫氧核糖-3,5-二苯甲酸酯 |
134877-43-3 |
詳細
|
| Gemcitabine impurity 8 |
吉西他濱雜質(zhì)9 |
2174019-90-8 |
詳細
|
| Gemcitabine impurity 9 |
2-脫氧-2,2-二氟-D-赤式戊呋喃酮糖-3,5-二苯甲酸酯 |
122111-02-8 |
詳細
|
| Gemcitabine impurity 10 |
3-(2,2-二甲基-1,3-二氧戊環(huán)-4-基)-2,2-二氟-3-羥基丙酸乙酯 |
928797-50-6 |
詳細
|
| Atorvastatin EP Impurity K |
阿托伐他汀甲酯 |
345891-62-5 |
詳細
|
| Avatrombopag impurity 45 |
阿伐曲泊帕雜質(zhì)408 |
832088-14-9 |
詳細
|
| Vancomycin Impurity 1 |
56-亞硝基-萬古霉素 |
155386-25-7 |
詳細
|
| Vancomycin EP Impurity D |
萬古霉素雜質(zhì) |
101485-50-1 |
詳細
|
| Vancomycin EP Impurity A |
萬古霉素雜質(zhì) |
91700-98-0 |
詳細
|
| Terbutaline EP Impurity D |
特布他林EP雜質(zhì)D |
94109-61-2 |
詳細
|
| Trifluridine Impurity 4 |
曲氟尿苷雜質(zhì)14 |
362607-81-6 |
詳細
|
| Terazosin EP Impurity N |
四氫糠酰哌嗪 |
63074-07-7 |
詳細
|
| Terazosin EP Impurity M |
1,4-二-2-糠?；哙?/td>
| 31350-27-3 |
詳細
|
| Sugammadex sodium Org199129-1 Impurity |
舒更葡糖鈉雜質(zhì)05 |
2412953-06-9 |
詳細
|
| Rapamycin impurity 5 |
Rapamycin Impurity 6 |
500733-49-3 |
詳細
|
| 28-epi-Rapamycin |
28-異帕雷帕霉素 |
253431-35-5 |
詳細
|
| Pitavastatin Impurity 3 |
匹伐他汀鈣中間體 |
154057-58-6 |
詳細
|
| Oxymetazoline EP Impurity B |
賽洛唑啉 |
526-36-3 |
詳細
|
| Norfloxacin EP Impurity H |
諾氟沙星EP雜質(zhì)H |
105440-01-5 |
詳細
|
| Medetomidine Impurity 20 |
右美托咪啶 3 |
104245-83-2 |
詳細
|
| Medetomidine Impurity 8 |
鹽酸左美托咪定 |
190000-46-5 |
詳細
|
| Moxifloxacin impurity 26 |
丙烯酸鹽反應(yīng)產(chǎn)物 |
161594-54-3 |
詳細
|
| Avatrombopag impurity 43 |
6-(4-(乙氧基羰基)哌啶-1-基)-5-氯吡啶-3-羧酸 |
931395-73-2 |
詳細
|
| Avatrombopag impurity 35 |
570403-04-2 |
570403-04-2 |
詳細
|
| Avatrombopag impurity 34 |
2,3-DICHLOROPYRIDINE-5-CARBONYL CHLORIDE |
54127-29-6 |
詳細
|
| Avatrombopag impurity 26 |
5-溴-4-(4-氯噻吩-2-基)噻唑-2-胺 |
2161380-87-4 |
詳細
|
| Avatrombopag impurity 8 |
2-溴-1-(4-氯-2-噻吩基)乙酮 |
677007-73-7 |
詳細
|
| Avatrombopag impurity 5 |
4-(5-氯-2-噻吩)-1,3-噻唑-2-胺 |
123971-45-9 |
詳細
|
| Rosuvastatin Impurity 9 |
Rosuvastatin D-5 Enatiomer Impurity |
2375865-91-9 |
詳細
|
| Latamoxef impurity 9 |
拉他莫西雜質(zhì)5 |
64076-52-4 |
詳細
|
| Latamoxef impurity 13 |
|
65664-73-5 |
詳細
|
| Levetiracetam EP Impurity C |
2-羥基吡啶 |
142-08-5 |
詳細
|
| Levetiracetam Impurity 8 |
4-氯丁酰氯 |
4635-59-0 |
詳細
|
| Levocetirizine Impurity 1 |
左氯替西汀酰胺雜質(zhì)鹽酸鹽 |
909779-33-5 |
詳細
|
| (S)-Cetirizine |
(S)-西替利嗪 |
130018-76-7 |
詳細
|
| Levocetirizine Impurity 11 |
Levocetirizine Impurity 4 |
70558-10-0 |
詳細
|
| Levocetirizine Impurity 12 |
鹽酸左西替利嗪SM雜質(zhì) |
109036-15-9 |
詳細
|
| Moxifloxacin impurity 3 |
6-羥基莫西沙星 |
2445515-66-0 |
詳細
|
| Moxifloxacin impurity 16 |
加替沙星雜質(zhì)15 |
2327019-81-6 |
詳細
|
| Bromoacetaldehyde |
溴乙醛 |
17157-48-1 |
詳細
|